Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer.
Saved in:
| Title: | Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer. |
|---|---|
| Authors: | Li C; Institute of Precision Medicine, Jining Medical University, Jining, China.; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas., He C; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas.; Department of Radiation Oncology, The First Affiliated Hospital, Xi'An Jiaotong University School of Medicine, Xi'An, China., Xu Y; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas., Xu H; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas., Tang Y; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas., Chavan H; Department of Pharmacology, Toxicology & Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas., Duan S; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas., Artigues A; Department of Biochemistry & Molecular Biology, The University of Kansas Medical Center, Kansas City, Kansas., Forrest ML; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas., Krishnamurthy P; Department of Pharmacology, Toxicology & Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas., Han S; Department of Radiation Oncology, The First Affiliated Hospital, Xi'An Jiaotong University School of Medicine, Xi'An, China., Holzbeierlein JM; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas., Li B; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas. |
| Source: | The Prostate [Prostate] 2019 May; Vol. 79 (6), pp. 628-639. Date of Electronic Publication: 2019 Jan 20. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30663084 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+C%22">Li C</searchLink>; Institute of Precision Medicine, Jining Medical University, Jining, China.; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas.<br /><searchLink fieldCode="AU" term="%22He+C%22">He C</searchLink>; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas.; Department of Radiation Oncology, The First Affiliated Hospital, Xi'An Jiaotong University School of Medicine, Xi'An, China.<br /><searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas.<br /><searchLink fieldCode="AU" term="%22Xu+H%22">Xu H</searchLink>; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas.<br /><searchLink fieldCode="AU" term="%22Tang+Y%22">Tang Y</searchLink>; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas.<br /><searchLink fieldCode="AU" term="%22Chavan+H%22">Chavan H</searchLink>; Department of Pharmacology, Toxicology & Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas.<br /><searchLink fieldCode="AU" term="%22Duan+S%22">Duan S</searchLink>; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas.<br /><searchLink fieldCode="AU" term="%22Artigues+A%22">Artigues A</searchLink>; Department of Biochemistry & Molecular Biology, The University of Kansas Medical Center, Kansas City, Kansas.<br /><searchLink fieldCode="AU" term="%22Forrest+ML%22">Forrest ML</searchLink>; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas.<br /><searchLink fieldCode="AU" term="%22Krishnamurthy+P%22">Krishnamurthy P</searchLink>; Department of Pharmacology, Toxicology & Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas.<br /><searchLink fieldCode="AU" term="%22Han+S%22">Han S</searchLink>; Department of Radiation Oncology, The First Affiliated Hospital, Xi'An Jiaotong University School of Medicine, Xi'An, China.<br /><searchLink fieldCode="AU" term="%22Holzbeierlein+JM%22">Holzbeierlein JM</searchLink>; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas.<br /><searchLink fieldCode="AU" term="%22Li+B%22">Li B</searchLink>; Department of Urology, The University of Kansas Medical Center, Kansas City, Kansas. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228101368%22">The Prostate</searchLink> [Prostate] 2019 May; Vol. 79 (6), pp. 628-639. <i>Date of Electronic Publication: </i>2019 Jan 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8101368 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0045 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202704137%22">02704137 </searchLink><i>NLM ISO Abbreviation: </i>Prostate <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30663084 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/pros.23767 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 628 Titles: – TitleFull: Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li C – PersonEntity: Name: NameFull: He C – PersonEntity: Name: NameFull: Xu Y – PersonEntity: Name: NameFull: Xu H – PersonEntity: Name: NameFull: Tang Y – PersonEntity: Name: NameFull: Chavan H – PersonEntity: Name: NameFull: Duan S – PersonEntity: Name: NameFull: Artigues A – PersonEntity: Name: NameFull: Forrest ML – PersonEntity: Name: NameFull: Krishnamurthy P – PersonEntity: Name: NameFull: Han S – PersonEntity: Name: NameFull: Holzbeierlein JM – PersonEntity: Name: NameFull: Li B IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2019 May Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1097-0045 Numbering: – Type: volume Value: 79 – Type: issue Value: 6 Titles: – TitleFull: The Prostate Type: main |
| ResultId | 1 |